PRESS RELEASE published on 09/11/2023 at 17:40, 1 year 2 months ago VALBIOTIS SA: Valbiotis presents the full results of the Phase II/III REVERSE-IT study: impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes
PRESS RELEASE published on 09/11/2023 at 17:40, 1 year 2 months ago VALBIOTIS SA: Valbiotis présente les résultats complets de l’étude de Phase II/III REVERSE-IT : efficacité remarquable de TOTUM•63 contre le prédiabète et les stades précoces du diabète de type 2
PRESS RELEASE published on 09/06/2023 at 17:40, 1 year 2 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 09/06/2023 at 17:40, 1 year 2 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Août 2023
PRESS RELEASE published on 08/04/2023 at 17:40, 1 year 3 months ago VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social - Juillet 2023
PRESS RELEASE published on 07/17/2023 at 17:40, 1 year 4 months ago VALBIOTIS SA: Bilan semestriel du contrat de liquidité
PRESS RELEASE published on 07/12/2023 at 17:40, 1 year 4 months ago Valbiotis announces its roadmap and strategic priorities on the eve of key milestones for its portfolio of innovative active substances
PRESS RELEASE published on 07/12/2023 at 17:40, 1 year 4 months ago Valbiotis annonce sa feuille de route et ses priorités stratégiques, à la veille d’étapes décisives pour son portefeuille de substances actives innovantes
PRESS RELEASE published on 07/03/2023 at 17:40, 1 year 4 months ago Valbiotis announces the appointment of Charlotte JEZEQUEL as Director of Human Relations and Executive Committee member
PRESS RELEASE published on 07/03/2023 at 17:40, 1 year 4 months ago Valbiotis annonce la nomination de Charlotte JEZEQUEL en tant que Directrice des Relations Humaines et son intégration au sein du Comité Exécutif
Published on 11/21/2024 at 13:00, 12 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 12 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 12 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 12 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 12 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 37 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 57 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 42 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 14 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 14 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 14 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 5 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 52 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
